BGM GroupBGM -0.37%53 Pretax Margin % is -35.79% as of Mar. 2025. GuruFocus rates BGM with a GF Score™ of 53/100. Among 952 Drug Manufacturers companies, BGM Group ranks worse than 83.72% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. BGM Group's Pre-Tax Income for the
six
months ended in Mar. 2025 was $-5.12 Mil. BGM Group's Revenue for the
six
months ended in Mar. 2025 was $14.31 Mil. Therefore, BGM Group's pretax margin for the quarter that ended in Mar. 2025 was -35.79%.
The historical rank and industry rank for BGM Group's Pretax Margin % or its related term are showing as below:
BGM's Pretax Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.295 * Ranked among companies with meaningful Pretax Margin % only.
BGM Group (NAS:BGM) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
BGM Group Pretax Margin % Related Terms
BGM Group Pretax Margin % Historical Data
* Premium members only.
The historical data trend for BGM Group's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BGM vs INCR, SCYX, CTOR: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, BGM Group's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BGM Group Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, BGM Group's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where BGM Group's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BGM Group (BGM) has a Pretax Margin % of -35.79% as of Mar. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on BGM Group and its competitors. According to the industry distribution chart, BGM Group ranks #797 out of 952 companies in the Drug Manufacturers industry, placing it in the top 83.7%.
Is BGM Group's Pretax Margin % too high?
BGM Group's current Pretax Margin % is -35.79%. Based on the distribution chart, BGM Group ranks #797 out of 952 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, BGM Group has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does BGM Group's Pretax Margin % compare to INCR and SCYX?
According to the Drug Manufacturers industry distribution chart, BGM Group ranks #797 out of 952 companies for Pretax Margin %. This places BGM Group in the lower half of its industry. The industry median Pretax Margin % is 7.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on BGM Group and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BGM Group's current Pretax Margin % is -35.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BGM Group stock overvalued right now?
BGM Group (BGM) has a current Pretax Margin % of -35.79%. The current Pretax Margin % is -35.79%. BGM Group's overall GF Score™ is 53/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For BGM Group (BGM), the current Pretax Margin % is -35.79% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
53GF Score
Get the complete analysis for BGM
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BGM has been successfully added to your 
